November 30, 2006 (Chicago) -- Magnetic resonance spectroscopic imaging (MRSI) shows no advantages over magnetic resonance imaging (MRI) alone for localization of peripheral zone prostate cancer in ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Excluding ...

MRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new research suggests. A new meta-analysis by investigators from Brigham and ...

A Yale-led study examines the potential environmental benefits of more carefully selecting patients for prostate biopsy in a way that can also spare low-yield and potentially harmful procedures. Yale ...

A prostate cancer screening strategy using MRI with targeted and standard biopsy reduced the detection of clinically insignificant cancers as well as unnecessary biopsies, researchers reported. Such ...

A novel MRI-guided procedure that uses therapeutic ultrasound effectively treats prostate cancer with minimal side effects, according to a new study. Researchers said the incision-free technique could ...

Less than 1% of patients who underwent the procedure under local analgesia and without antibiotic prophylaxis experienced post-biopsy infection, a study found. Transperineal magnetic resonance imaging ...

WESTON, Fla. — Research has found benefit from a different way of screening some men for prostate cancer. Dr. Alberto Pieretti, a urologist with Cleveland Clinic Weston, said rather than standard ...

A large screening trial showed that using prostate-specific antigen density (PSAD) before MRI prevented overdiagnosis and lowered resource use while preserving the detection of clinically significant ...

The MRI-based prostate biopsy risk stratification tools with the greatest accuracy were the RPCRC-MRI and PLUM models Among MRI-based risk calculators for prostate biopsy, 2 models provide more ...